跳至主要内容
临床试验/NCT01714687
NCT01714687已完成不适用

Comparison of Balloon Sinuplasty In-Office Versus Medical Management for Recurrent Acute Sinusitis Patients: A Randomized Controlled Study (CABERNET)

Integra LifeSciences Corporation5 个研究点 分布在 1 个国家目标入组 59 人开始时间: 2012年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
59
试验地点
5
主要终点
CSS Total Score Change From Baseline to 24 Week Visit

研究概览

简要总结

This post-market study aims to compare health outcomes for Recurrent Acute Rhinosinusitis (RARS) patients treated with balloon sinus dilation (BSD) versus medical management alone.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 19 years of age or greater
  • diagnosis of recurrent acute rhinosinusitis
  • suitable candidate for office-based procedure
  • willing and able to read and sign informed consent and remain compliant with protocol and study procedures
  • able to read and understand English

排除标准

  • diagnosis of chronic rhinosinusitis
  • prior sinus surgery
  • physician determined need for ancillary procedures
  • known immune deficiency, ciliary dysfunction and/or autoimmune disease
  • clinically significant illness that may interfere with evaluation of the study
  • participation in clinical studies 6 months prior to study participation
  • pregnant or lactating females

结局指标

主要结局

CSS Total Score Change From Baseline to 24 Week Visit

时间窗: 24 Week Visit

The Chronic Sinusitis Survey (CSS) is a 6 question, duration-based survey to evaluate surgical outcomes for CRS patients. The CSS asks three questions about symptoms and three questions about medication usage and yields a symptom subscore, a medication subscore, and a total score. Scale values include "0 Weeks" (minimum), "1-2 Weeks", "3-4 Weeks", "5-6 Weeks", and "7-8 Weeks" (maximum). The severity of symptoms is scored 0 (none) to 4 (severe), and a total score is calculated from 0 (worst) to 100 (best). Subscores are averaged to calculate a total score. Higher score indicates better outcomes. The Primary Endpoint is the comparison of change in total CSS score over 24 weeks for subjects randomized to BSD versus medical management only. Change is assessed by using the Mean Change for the CSS total score at 24 weeks compared to baseline. (24-week CSS total score minus Baseline CSS total score). Higher score indicates greater improvement.

次要结局

  • Return to Normal Activity(2 week)
  • Frequency of Second Procedure(Up to 24 weeks)
  • RSDI Total and Sub-score Changes From Baseline Over 48 Weeks(8, 24, and 48 Weeks)
  • Medication Usage at 24 and 48 Weeks(24 Weeks and 48 Weeks)
  • Sinus Infections and Sinus Severity - Part 1(24 Weeks and 48 Weeks)
  • CSS Sub-score Changes From Baseline Over 48 Weeks, and CSS Total Score Over 48 Weeks(8, 16, 24, 32, 40, and 48 Weeks)
  • Unscheduled Medical Care Visits Due to Sinusitis(24 Weeks and 48 Weeks)
  • Sinus Infections and Sinus Severity - Part 2(24 Weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验